Navigation Links
NeuroSigma Awarded Fast Track SBIR Grant by the NIH for Development of Implantable sTNS System for Drug Resistant Epilepsy
Date:2/4/2013

LOS ANGELES, Feb. 4, 2013 /PRNewswire/ -- NeuroSigma, Inc., a California-based medical device company, today announced it received a Notice of Award, for a Fast Track Small Business Innovation Research (SBIR) grant, from the National Institute of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health (NIH). Phase I of the project is budgeted in the amount of $600,000, with $3 Million budgeted for Phase II, subject to the availability of funds and satisfactory progress by NeuroSigma. 

The funding supports further development of NeuroSigma's implantable subcutaneous trigeminal nerve stimulation (sTNSTM) System, culminating in a pilot human trial of sTNS in patients with drug resistant epilepsy (DRE). The project builds on the positive results from the randomized controlled trial of NeuroSigma's non-invasive, external TNS (eTNSTM) System, as reported online in the January 30, 2013 issue of Neurology®.  The eTNS System is composed of an external pulse generator and electric patches placed on the forehead, primarily while the patient is asleep.

Together, eTNS and sTNS offer a complementary platform.  Some patients may choose to remain on eTNS whereas others may opt to transition to sTNS.  eTNS may serve as a means to screen for sTNS candidates prior to committing to sTNS surgery. 

(Photo: http://photos.prnewswire.com/prnh/20130204/LA53356)

Once both sTNS and eTNS are approved by regulatory agencies the following integrated therapy path would be available.  First, patients could commence with the eTNS treat
'/>"/>

SOURCE NeuroSigma, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. NeuroSigma Announces Receipt of Notice of Allowance of U.S. Patent Application Related to External Trigeminal Nerve Stimulation (eTNS) for the Treatment of Neuropsychiatric Disorders
2. NeuroSigma Receives CE Certification
3. NeuroSigma Receives Global Quality Control Certification
4. NeuroSigma Subsidiary Acquires Thin-Film Nitinol Fabrication Patent Portfolio
5. Global BioClinical Awarded Cancer Genome Atlas (TCGA) Contract
6. Dr. Alex Matter Awarded 2013 Szent-Gyorgyi Prize for Progress in Cancer Research
7. Genalyte Awarded $500,000 SBIR Grant To Develop Multiplexed Assays For Early Detection And Monitoring Of Type 1 Diabetes
8. Florida Blue Awarded Certified Center of Excellence by BenchmarkPortal for Second Consecutive Year
9. Artemis Diagnostics awarded two grants from Technology Strategy Board to develop cancer imaging technology
10. Elbit Imaging Ltd. Announces InSightecs ExAblate Neuro System Awarded European CE Mark for Non-invasive Treatment of Neurological Disorders in the Brain
11. Sigma-taus Antimalarial Awarded "Project of the Year" 2011 by Medicines for Malaria Venture
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... , Nov. 25, 2014 Reinforcing its commitment ... (NYSE: PHG AEX: PHIA) today ... Administration (FDA) for its IQon Spectral CT , ... first-of-its kind technology adds a new dimension to Computed ... ability to characterize structures based on their material content ...
(Date:11/26/2014)... 2014   Heska Corporation (NASDAQ: HSKA ... provider of advanced veterinary diagnostic and other specialty veterinary ... Chair, will attend The Benchmark Company, LLC,s Micro Cap Discovery ... be held at The Palmer House Hilton, 17 E. Monroe ... to 2:30 p.m. Please email hska@haydenir.com or contact ...
(Date:11/26/2014)... 2014  Breckenridge Pharmaceutical, Inc. announced today that ... with Pii (Pharmaceutics International, Inc.) ( Hunt ... Pii expect to develop and commercialize several new ... will develop, manufacture and supply the products, and ... its own label.  The drugs, comprised of four ...
Breaking Medicine Technology:Philips receives FDA 510(k) clearance for IQon Spectral CT 2Philips receives FDA 510(k) clearance for IQon Spectral CT 3Heska to Attend Benchmark Micro Cap Discovery Conference 2Breckenridge Pharmaceutical signs Multi-Product Generic Agreement with Pharmaceutics International, Inc. 2
... Cell Therapeutics, Inc. (CTI),(Nasdaq and MTA: CTIC) today announced that the following presentations,will ... formerly XYOTAX(TM)),at the 44th American Society of Clinical Oncology (ASCO) Annual Meeting,May 30 through ... Poster # ... (Abstract#) Sat., ...
... First and Only Treatment for Hunter Syndrome Now Approved in ... ... Worldwide, BASINGSTOKE, England and CAMBRIDGE, Massachusetts, May ... company, announced that ELAPRASE(R),(idursulfase), a human enzyme replacement therapy for ...
Cached Medicine Technology:Cell Therapeutics, Inc. (CTI) Announces Presentations at American Society of Clinical Oncology (ASCO) Annual Meeting 2Cell Therapeutics, Inc. (CTI) Announces Presentations at American Society of Clinical Oncology (ASCO) Annual Meeting 3Shire Announces Approval of ELAPRASE(R) (idursulfase) in Brazil 2Shire Announces Approval of ELAPRASE(R) (idursulfase) in Brazil 3Shire Announces Approval of ELAPRASE(R) (idursulfase) in Brazil 4Shire Announces Approval of ELAPRASE(R) (idursulfase) in Brazil 5
(Date:11/26/2014)... November 26, 2014 ISI Telemanagement ... solutions, has been award the 2014 Lync ... This award comes as a great honor to ... the Lync ecosystem. Specifically, ISI offers an integrated ... of Lync communication, including voice, video, Lync IM, ...
(Date:11/26/2014)... 26, 2014 Bunion Bootie, the newest ... in an early celebration of the early holiday shopping ... offered at the promotional price of $29.95 each (normally ... addition to any automatic discounts applied when buying more ... website for complete details. It’s simple: purchasing more ...
(Date:11/26/2014)... (PRWEB) November 26, 2014 Sonoran ... ANP-BC, recently received the Distinguished Preceptorship Award from ... for her role in the advancement of nurse ... of an individual who had made a significant ... NPs. The American Association of Nurse Practitioners (AANP) ...
(Date:11/26/2014)... Teens prescribed anti-anxiety or sleep medications are much ... teens, a new study warns. The findings ... on teenagers before prescribing these drugs to them, ... realize the abuse potential," said lead researcher Carol ... School of Nursing. "These drugs produce highly attractive ...
(Date:11/26/2014)... Randy Dotinga HealthDay Reporter ... such as Prilosec and Nexium may disrupt the makeup of ... infections and other problems, a small new study suggests. ... more likely users will become ill, and study authors aren,t ... However, these antacids "should be used at the lowest ...
Breaking Medicine News(10 mins):Health News:ISI Telemanagement Solutions, Inc. has been Awarded the 2014 Microsoft Lync Pioneer Award 2Health News:Bunion Bootie Temporarily Lowering Prices for Holiday Shopping, Starting Today! 2Health News:Sonoran Nurse Receives Distinguished Preceptorship Award from The American Association of Nurse Practitioners 2Health News:Teens Given Anxiety, Sleep Meds May Be at Risk for Drug Abuse 2Health News:Could Popular Heartburn Drugs Upset Your 'Good' Gut Bugs? 2Health News:Could Popular Heartburn Drugs Upset Your 'Good' Gut Bugs? 3
... HealthDay Reporter , MONDAY, April 30 (HealthDay News) -- ... disease, but most don,t know it and for most it ... has been debate about whether healthy people should be screened ... U.S. Preventive Services Task Force (USPSTF) says no. "The ...
... HealthDay Reporter , MONDAY, April 30 (HealthDay News) ... depending on where you,re treated in the United States, according ... that follow five simple strategies -- including good teamwork and ... survival rates of other medical centers, the study found. ...
... HealthDay Reporter , MONDAY, April 30 (HealthDay News) ... interferes with breast-feeding is wrong, a new small study ... born between June 2010 and August 2011, Oregon Health ... pacifiers -- also known as binkies, corks and soothers ...
... Like a police officer calling for backup while also keeping ... the brain take a two-tier approach to fighting off a ... finds. For the first time, the scientists managed to ... locked onto a model of virus-infected brain cells, while also ...
... competent than other physicians regarding knowledge of patient imaging ... The study conducted at Thomas Jefferson University in Philadelphia ... 2,685 non-radiology physicians. "On a scale of one ... patient safety was rated as 3.1 by radiologists and ...
... images from the "cloud" making it faster for them ... those physicians might be, according to a preliminary report ... academic institutions., The image share project includes the University ... Clinic in Rochester, MN, the University of Maryland in ...
Cached Medicine News:Health News:Routine Kidney Disease Screening Not Worthwhile, Experts Say 2Health News:Routine Kidney Disease Screening Not Worthwhile, Experts Say 3Health News:Heart Attack Survival Varies Widely Among Hospitals, Study Finds 2Health News:Heart Attack Survival Varies Widely Among Hospitals, Study Finds 3Health News:Pacifiers Don't Discourage Breast-Feeding, Study Says 2Health News:Pacifiers Don't Discourage Breast-Feeding, Study Says 3Health News:How does the immune system fight off threats to the brain? New research yields fresh insight 2Health News:How does the immune system fight off threats to the brain? New research yields fresh insight 3Health News:Image share project gives patients and physicians anytime, anywhere access to medical images 2
... Menicon Super EX is a rigid ... one of its specific characteristics as hard ... correction and show excellent performance against astigmatism. ... material is the combination of fluoromethacrylate, Siloxanylmethacrylate ...
Magniclear is the first presbyopic lens to combine the clear distance optics of a spherical lens, the intermediate visual performance of a multifocal and the predictably crisp, near power of a bifoca...
Boston Multivision design is manufactured in Boston ES material for early presbyope patients. Boston Multivision lens provides crisp, clear vision at near, intermediate, and far distances and excelle...
... to stain intraocular membranes in vitreoretinal surgery, ... injecting Membraneblue in an air-filled vitreous cavity, ... the dye. After removal of all excess ... can easily be distinguished from the underlying, ...
Medicine Products: